Who Owns Corbus Pharmaceuticals Stock?
NASDAQ: CRBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 5.24 -0.57%
Ownership breakdown
- Held by institutions
- 84.15%
- Held by insiders
- 1.24%
- Institutional holders
- 141
- Institutions 84.2%
- Insiders 1.2%
- Public and other 14.6%
Who owns Corbus Pharmaceuticals stock?
Institutional investors own about 84.2% of Corbus Pharmaceuticals's shares, spread across 141 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.24% of CRBP.
The largest institutional holders are Cormorant Asset Management, LP (12.56%), Orbimed Advisors LLC. (9.30%) and Blackrock Inc. (7.13%). Together, the top 10 institutions control 53.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their CRBP positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CRBP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Cormorant Asset Management, LP | 2.34M | 12.56% | 0.0% |
| Orbimed Advisors LLC. | 1.74M | 9.30% | 0.0% |
| Blackrock Inc. | 1.33M | 7.13% | +390.0% |
| Aberdeen Group plc | 1.32M | 7.08% | 0.0% |
| Vanguard Capital Management LLC | 760.94K | 4.08% | +3.7% |
| Jones Hill Capital LP | 653.57K | 3.50% | +100.0% |
| Prosight Management, Lp | 650.00K | 3.48% | -6.8% |
| Stonepine Capital Management, LLC | 425.00K | 2.28% | +10.8% |
| Geode Capital Management, LLC | 423.37K | 2.27% | +126.4% |
| Adar1 Capital Management, LLC | 421.79K | 2.26% | +27.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CRBP
| Fund | Shares | % Held |
|---|---|---|
| abrdn Healthcare Investors | 778.03K | 4.17% |
| abrdn Life Sciences Investors | 543.72K | 2.91% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 533.58K | 2.86% |
| iShares Trust-iShares Russell 2000 ETF | 400.82K | 2.15% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 208.31K | 1.12% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 179.56K | 0.96% |
| iShares Trust-iShares Russell 2000 Value ETF | 155.50K | 0.83% |
| Fidelity Covington Trust-Fidelity Enhanced Small Cap Core ETF | 87.39K | 0.47% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 58.38K | 0.31% |
| iShares Trust-iShares Micro-Cap ETF | 56.55K | 0.30% |
Frequently asked questions
Who is the largest shareholder of Corbus Pharmaceuticals?
Cormorant Asset Management, LP is the largest institutional shareholder of CRBP, owning 12.56% of shares outstanding (2.34M shares) as of its latest 13F filing.
What percentage of Corbus Pharmaceuticals is owned by institutions?
Institutions own about 84.2% of CRBP shares and 85.2% of the public float.
How much of Corbus Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 1.24% of CRBP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.